Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Effectiveness of maternal pertussis vaccination in England: an observational studyThe Lancet (British edition), 2014-10, Vol.384 (9953), p.1521-1528 [Peer Reviewed Journal]Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright Elsevier Limited Oct 25, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)60686-3 ;PMID: 25037990 ;CODEN: LANCAOFull text available |
|
2 |
Material Type: Article
|
Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control studyNature communications, 2022-09, Vol.13 (1), p.5736-5736, Article 5736 [Peer Reviewed Journal]Crown 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-022-33378-7Full text available |
|
3 |
Material Type: Article
|
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort studyThe Lancet infectious diseases, 2018-04, Vol.18 (4), p.441-451 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 1, 2018 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(18)30052-5 ;PMID: 29395999Full text available |
|
4 |
Material Type: Article
|
Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort studyThe Lancet (British edition), 2016-12, Vol.388 (10061), p.2775-2782 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 3, 2016 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)31921-3 ;PMID: 28100432 ;CODEN: LANCAOFull text available |
|
5 |
Material Type: Article
|
Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in EnglandNature medicine, 2022-04, Vol.28 (4), p.831-837 [Peer Reviewed Journal]2022. Crown. ;Crown 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Crown 2022 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-022-01699-1 ;PMID: 35045566Full text available |
|
6 |
Material Type: Article
|
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control studyBMJ (Online), 2021-05, Vol.373, p.n1088-n1088 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n1088 ;PMID: 33985964Full text available |
|
7 |
Material Type: Article
|
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) VariantNew England Journal of Medicine, 2021-08, Vol.385 (7), p.585-594 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2108891 ;PMID: 34289274Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: a national, observational, test-negative, case-control studyThe Lancet infectious diseases, 2023-04, Vol.23 (4), p.435-444 [Peer Reviewed Journal]2023 ;Crown Copyright © 2023 Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;Copyright Elsevier Limited Apr 2023 ;Crown Copyright © 2022 Published by Elsevier Ltd. 2023 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(22)00729-0 ;PMID: 36436536Full text available |
|
9 |
Material Type: Article
|
Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in EnglandThe New England journal of medicine, 2020-01, Vol.382 (4), p.309-317 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1901229 ;PMID: 31971676Full text available |
|
10 |
Material Type: Article
|
Duration of Protection against Mild and Severe Disease by Covid-19 VaccinesNew England Journal of Medicine, 2022-01, Vol.386 (4), p.340-350 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2115481 ;PMID: 35021002Digital Resources/Online E-Resources |
|
11 |
Material Type: Article
|
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in EnglandNature communications, 2021-12, Vol.12 (1), p.7217-7217, Article 7217 [Peer Reviewed Journal]2021. Crown. ;Crown 2021. corrected publication 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Crown 2021, corrected publication 2022 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-27410-5 ;PMID: 34893611Full text available |
|
12 |
Material Type: Article
|
Effectiveness of BNT162b2 against COVID-19 in adolescentsThe Lancet infectious diseases, 2022-05, Vol.22 (5), p.581-583 [Peer Reviewed Journal]2022 Elsevier Ltd ;2022. Elsevier Ltd ;2022 Published by Elsevier Ltd. 2022 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(22)00177-3 ;PMID: 35325619Full text available |
|
13 |
Material Type: Article
|
Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in AustraliaThe New England journal of medicine, 2020-01, Vol.382 (4), p.318-327 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1900236 ;PMID: 31971677Full text available |
|
14 |
Material Type: Article
|
Summary of evidence to reduce the two-dose infant priming schedule to a single dose of the 13-valent pneumococcal conjugate vaccine in the national immunisation programme in the UKThe Lancet infectious diseases, 2021-04, Vol.21 (4), p.e93-e102 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30492-8 ;PMID: 33129426Full text available |
|
15 |
Material Type: Article
|
Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004–11: an observational studyThe Lancet infectious diseases, 2014-04, Vol.14 (4), p.301-307 [Peer Reviewed Journal]Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 2014 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(13)70332-3 ;PMID: 24508198 ;CODEN: LANCAOFull text available |
|
16 |
Material Type: Article
|
The changing and dynamic epidemiology of meningococcal diseaseVaccine, 2012-05, Vol.30, p.B26-B36 [Peer Reviewed Journal]Elsevier Ltd ;2011 Elsevier Ltd ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2011.12.032 ;PMID: 22178525Full text available |
|
17 |
Material Type: Article
|
Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000-June 30, 2016Emerging infectious diseases, 2019-09, Vol.25 (9), p.1708-1718 [Peer Reviewed Journal]COPYRIGHT 2019 U.S. National Center for Infectious Diseases ;COPYRIGHT 2019 U.S. National Center for Infectious Diseases ;ISSN: 1080-6040 ;EISSN: 1080-6059 ;DOI: 10.3201/eid2509.180747 ;PMID: 31441745Full text available |
|
18 |
Material Type: Article
|
Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in EnglandNature communications, 2022-12, Vol.13 (1), p.7688-7688 [Peer Reviewed Journal]2022. Crown. ;Crown 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Crown 2022 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-022-35168-7 ;PMID: 36509743Full text available |
|
19 |
Material Type: Article
|
Should the UK introduce a universal childhood varicella vaccination programme?Archives of disease in childhood, 2016-01, Vol.101 (1), p.2-3 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Copyright: 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;ISSN: 0003-9888 ;EISSN: 1468-2044 ;DOI: 10.1136/archdischild-2015-308730 ;PMID: 26342095 ;CODEN: ADCHAKFull text available |
|
20 |
Material Type: Article
|
Measles: the legacy of low vaccine coverageArchives of disease in childhood, 2013-10, Vol.98 (10), p.752-754 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2014 INIST-CNRS ;Copyright: 2013 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0003-9888 ;EISSN: 1468-2044 ;DOI: 10.1136/archdischild-2013-304292 ;PMID: 23898160 ;CODEN: ADCHAKFull text available |